Preclinical Detection of Variant CJD and BSE Prions in Blood

English version České info

Variant Creutzfeldt Jakob Disease (vCJD) cases were identified in patients who received blood products that had been prepared from donors who later developed the disease. The blood borne transmission of vCJD is a major concern for blood transfusion banks, plasma derived products manufacturers and public health authorities. A vCJD blood screening test would represent an ideal solution for identifying donors/blood donations that might be at risk. In this study, we describe a blood assay which is based on the in vitro amplification of vCJD agent by Protein Misfolding Cyclic Amplification (PMCA). In vCJD animal models (sheep and primate), the assay enabled the identification of infected individuals in a very early stage of the asymptomatic incubation phase. We also provide evidence of the high specificity and the high analytical sensitivity of this assay using blood samples from vCJD affected and healthy patients.

Vyšlo v časopise: Preclinical Detection of Variant CJD and BSE Prions in Blood. PLoS Pathog 10(6): e32767. doi:10.1371/journal.ppat.1004202
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004202

Souhrn

Zdroje

1. BruceME, WillRG, IronsideJW, McConnellI, DrummondD, et al. (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent [see comments]. Nature 389: 498–501.

2. HerzogC, RiviereJ, Lescoutra-EtchegarayN, CharbonnierA, LeblancV, et al. (2005) PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease. J Virol 79: 14339–14345.

3. HoustonF, FosterJD, ChongA, HunterN, BostockCJ (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356: 999–1000.

4. LlewelynCA, HewittPE, KnightRS, AmarK, CousensS, et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417–421.

5. PedenAH, HeadMW, RitchieDL, BellJE, IronsideJW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527–529.

6. PedenA, McCardleL, HeadMW, LoveS, WardHJ, et al. (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16: 296–304.

7. GarskeT, GhaniAC (2010) Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS One 5: e15626.

8. HiltonDA, GhaniAC, ConyersL, EdwardsP, McCardleL, et al. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203: 733–739.

9. GillON, SpencerY, Richard-LoendtA, KellyC, DabaghianR, et al. (2013) Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347: f5675.

10. BeringueV, HerzogL, JaumainE, ReineF, SibilleP, et al. (2012) Facilitated cross-species transmission of prions in extraneural tissue. Science 335: 472–475.

11. CooperJK, LadhaniK, MinorP (2012) Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets. Vox Sang 102: 100–109.

12. DouetJY, ZafarS, Perret-LiaudetA, LacrouxC, LuganS, et al. (2014) Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis 20: 114–117.

13. BrownP, RohwerRG, DunstanBC, MacAuleyC, GajdusekDC, et al. (1998) The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38: 810–816.

14. LacrouxC, ViletteD, Fernandez-BorgesN, LitaiseC, LuganS, et al. (2012) Prionemia and leuco-platelet associated infectivity in sheep TSE models. J Virol 86 (4) 2056–66.

15. MathiasonCK, Hayes-KlugJ, HaysSA, PowersJ, OsbornDA, et al. (2010) B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease. J Virol 84: 5097–5107.

16. McCutcheonS, Alejo BlancoAR, HoustonEF, de WolfC, TanBC, et al. (2011) All Clinically-Relevant Blood Components Transmit Prion Disease following a Single Blood Transfusion: A Sheep Model of vCJD. PLoS One 6: e23169.

17. SaborioGP, PermanneB, SotoC (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810–813.

18. CastillaJ, SaaP, SotoC (2005) Detection of prions in blood. Nat Med 11: 982–985.

19. ThorneL, TerryLA (2008) In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89: 3177–3184.

20. JonesM, PedenAH, YullH, WightD, BishopMT, et al. (2009) Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 49: 376–384.

21. JonesM, PedenAH, ProwseCV, GronerA, MansonJC, et al. (2007) In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 213: 21–26.

22. SimmonsHA, SimmonsMM, SpencerYI, ChaplinMJ, PoveyG, et al. (2009) Atypical scrapie in sheep from a UK research flock which is free from classical scrapie. BMC Vet Res 5: 8.

23. LacrouxC, CorbiereF, TabouretG, LuganS, CostesP, et al. (2007) Dynamics and genetics of PrPSc placental accumulation in sheep. J Gen Virol 88: 1056–1061.

24. MorenoCR, Moazami-GoudarziK, LaurentP, CazeauG, AndreolettiO, et al. (2007) Which PrP haplotypes in a French sheep population are the most susceptible to atypical scrapie? Arch Virol 152: 1229–1232.

25. ComoyEEC, JaffreN, MikolJ, DurandV, LuccantoniS, et al. (2013) Contaminated Blood Products Induce an Atypical Prion Disease in Primates in the Absence of Detectable Abnormal Prion Protein. Vox Sanguinis 105: 198–198.

26. EdgeworthJA, FarmerM, SiciliaA, TavaresP, BeckJ, et al. (2011) Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377: 487–493.

27. Uro-CosteE, CassardH, SimonS, LuganS, BilheudeJM, et al. (2008) Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 4: e1000029.

28. CastillaJ, Gutierrez AdanA, BrunA, PintadoB, RamirezMA, et al. (2003) Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch Virol 148: 677–691.

29. Le DurA, BeringueV, AndreolettiO, ReineF, LaiTL, et al. (2005) A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A 102: 16031–16036.

30. WeissmannC, FischerM, RaeberA, BuelerH, SailerA, et al. (1998) The use of transgenic mice in the investigation of transmissible spongiform encephalopathies. Rev Sci Tech 17: 278–290.

31. BeringueV, HerzogL, ReineF, Le DurA, CasaloneC, et al. (2008) Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg Infect Dis 14: 1898–1901.

32. FischerM, RulickeT, RaeberA, SailerA, MoserM, et al. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. Embo J 15: 1255–1264.

33. KupferL, EidenM, BuschmannA, GroschupMH (2007) Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras. Biochim Biophys Acta 1772: 704–713.

34. GroschupMH, BuschmannA (2008) Rodent models for prion diseases. Vet Res 39: 32.

35. AndreolettiO, OrgeL, BenestadSL, BeringueV, LitaiseC, et al. (2011) Atypical/Nor98 scrapie infectivity in sheep peripheral tissues. PLoS Pathog 7: e1001285.

36. EspinosaJC, AndreolettiO, CastillaJ, HervaME, MoralesM, et al. (2007) Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice. J Virol 81: 835–843.

37. EspinosaJC, HervaME, AndreolettiO, PadillaD, LacrouxC, et al. (2009) Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie. Emerg Infect Dis 15: 1214–1221.

38. FeraudetC, MorelN, SimonS, VollandH, FrobertY, et al. (2005) Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 280: 11247–11258.

39. BaronTG, BiacabeAG, BencsikA, LangeveldJP (2006) Transmission of new bovine prion to mice. Emerg Infect Dis 12: 1125–1128.

40. KociskoDA, ComeJH, PriolaSA, ChesebroB, RaymondGJ, et al. (1994) Cell-free formation of protease-resistant prion protein. Nature 370: 471–474.

41. BossersA, BeltP, RaymondGJ, CaugheyB, de VriesR, et al. (1997) Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci U S A 94: 4931–4936.

42. BossersA, de VriesR, SmitsMA (2000) Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 74: 1407–1414.

43. HoriuchiM, PriolaSA, ChabryJ, CaugheyB (2000) Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci U S A 97: 5836–5841.

44. RaymondGJ, BossersA, RaymondLD, O'RourkeKI, McHollandLE, et al. (2000) Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. Embo J 19: 4425–4430.

45. RaymondGJ, HopeJ, KociskoDA, PriolaSA, RaymondLD, et al. (1997) Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388: 285–288.

46. PanzaG, LuersL, StohrJ, Nagel-StegerL, WeissJ, et al. (2010) Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro. PLoS One 5: e14283.

47. CollingeJ, ClarkeAR (2007) A general model of prion strains and their pathogenicity. Science 318: 930–936.

48. BarriaMA, IronsideJW, HeadMW (2014) Exploring the zoonotic potential of animal prion diseases: In vivo and in vitro approaches. Prion 8 [epub ahead of print].

49. CastillaJ, MoralesR, SaaP, BarriaM, GambettiP, et al. (2008) Cell-free propagation of prion strains. Embo J 27: 2557–2566.

50. GreenKM, CastillaJ, SewardTS, NapierDL, JewellJE, et al. (2008) Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog 4: e1000139.

51. PadillaD, BeringueV, EspinosaJC, AndreolettiO, JaumainE, et al. (2011) Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog 7: e1001319.

52. ArsacJN, BetempsD, MorignatE, FeraudetC, BencsikA, et al. (2009) Transmissibility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression and donor prion genotype. PLoS One 4: e7300.

53. CordierC, BencsikA, PhilippeS, BetempsD, RonzonF, et al. (2006) Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59). J Gen Virol 87: 3763–3771.

54. BeringueV, AndreolettiO, Le DurA, EssalmaniR, VilotteJL, et al. (2007) A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission. J Neurosci 27: 6965–6971.

55. JacksonGS, Burk-RafelJ, EdgeworthJA, SiciliaA, AbdilahiS, et al. (2014) A highly specific blood test for vCJD. Blood 123: 452–453.

56. JacksonGS, Burk-RafelJ, EdgeworthJA, SiciliaA, AbdilahiS, et al. (2014) Population Screening for Variant Creutzfeldt-Jakob Disease Using a Novel Blood Test: Diagnostic Accuracy and Feasibility Study. JAMA Neurol 71 (4) 421–8.

57. MeadS, WadsworthJD, PorterMC, LinehanJM, PietkiewiczW, et al. (2014) Variant creutzfeldt-jakob disease with extremely low lymphoreticular deposition of prion protein. JAMA Neurol 71: 340–343.

58. VamvakasEC (2011) Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented? Transfus Med Rev 25: 133–144.

59. CossedduGM, NonnoR, VaccariG, BucalossiC, Fernandez-BorgesN, et al. (2011) Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog 7: e1002370.

60. MoudjouM, SibilleP, FichetG, ReineF, ChapuisJ, et al. (2013) Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification. MBio 5: e00829–00813.

61. MaysCE, YeomJ, KangHE, BianJ, KhaychukV, et al. (2011) In vitro amplification of misfolded prion protein using lysate of cultured cells. PLoS One 6: e18047.

62. AtarashiR, WilhamJM, ChristensenL, HughsonAG, MooreRA, et al. (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5: 211–212.

63. OrruCD, WilhamJM, VascellariS, HughsonAG, CaugheyB (2012) New generation QuIC assays for prion seeding activity. Prion 6: 147–52.

64. BessenRA, ShearinH, MartinkaS, BoharskiR, LoweD, et al. (2010) Prion shedding from olfactory neurons into nasal secretions. PLoS Pathog 6: e1000837.

65. PedenAH, McGuireLI, ApplefordNE, MallinsonG, WilhamJM, et al. (2012) Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J Gen Virol 93: 438–449.

66. OrruCD, WilhamJM, RaymondLD, KuhnF, SchroederB, et al. (2011) Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2: e00078–00011.